BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 755643)

  • 1. Influence of angiotensin antagonists on renal vascular resistance and prostaglandin E release.
    Sugawara S; Zimmerman BG
    Clin Exp Hypertens (1978); 1978; 1(1):11-24. PubMed ID: 755643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of [Sar1, Ala8]angiotensin II on renal vascular resistance.
    Satoh S; Zimmerman BG
    Am J Physiol; 1975 Sep; 229(3):640-5. PubMed ID: 1211457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graded effects of saralasin on prostaglandin E, plasma renin activity and renal blood flow in anaesthetized dogs.
    Wong PC; Zimmerman BG
    Clin Exp Pharmacol Physiol; 1983; 10(3):211-8. PubMed ID: 6354528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
    Arlart IP; Rosenthal J; Wagner H; Adam WE; Nobbe F; Franz HE
    Contrib Nephrol; 1978; 11():170-4. PubMed ID: 699587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
    Zimmerman BG; Goering JL; Raich PC
    Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effect of meclofenamate in presence and absence of superfusion bioassay.
    Satoh S; Zimmerman BG
    Am J Physiol; 1976 Mar; 230(3):711-4. PubMed ID: 1266974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the renin-angiotensin system on the effect of prostaglandin synthesis inhibitors in the renal vasculature.
    Satoh S; Zimmerman BG
    Circ Res; 1975 Jun; 36(6 Suppl 1):89-96. PubMed ID: 805674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of saralasin infusion on bilateral renal function in two-kidney, one-clip Goldblatt hypertensive rats.
    Huang WC; Ploth DW; Navar LG
    Clin Sci (Lond); 1982 Jun; 62(6):573-9. PubMed ID: 7083749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of the competitive angiotensin II antagonist saralasin during the initial phase of glycerol-induced acute renal failure of the rat.
    Greven J; Klein H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Dec; 301(2):139-43. PubMed ID: 600326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of captopril, a converting enzyme inhibitor on renal vascular resistance in pentobarbital anesthetized dogs.
    Satoh S; Fujisawa S; Tanaka R; Nakai K
    Jpn J Pharmacol; 1980 Aug; 30(4):515-9. PubMed ID: 7009942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of captopril-induced renal vasodilatation in anesthetized dogs after nonhypotensive hemorrhage.
    Wong PC; Zimmerman BG
    J Pharmacol Exp Ther; 1980 Oct; 215(1):104-9. PubMed ID: 7005423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of saralasin on renal function of the rat.
    Hofbauer KG; Bauereiss K; Zschiedrich H; Gross F
    Prog Biochem Pharmacol; 1976; 12():63-83. PubMed ID: 1019171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients].
    Higuma K; Fujishima S; Shionoiri H; Tochikubo O; Uneda S; Fujiki Y; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):425-35. PubMed ID: 6381833
    [No Abstract]   [Full Text] [Related]  

  • 14. Contribution of prostaglandins to the renal circulation in conscious, anesthetized, and laparotomized dogs.
    Terragno NA; Terragno DA; McGiff JC
    Circ Res; 1977 Jun; 40(6):590-5. PubMed ID: 404093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the ability of two angiotensin II receptor blocking drugs, 1-Sar; 8-Ala angiotensin II and 1-Sar, 8-Ile angiotensin II, to modify the regulation of glomerular filtration rate in the cat.
    Johns EJ
    Br J Pharmacol; 1980; 71(2):499-506. PubMed ID: 7470759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of biological effects of three angiotensin II antagonists in sodium depleted hypertensive patients.
    Ogihara T; Nakamaru M; Higaki J; Hata T; Kumagai A; Kumahara Y
    Med J Osaka Univ; 1983 Sep; 34(1-2):21-5. PubMed ID: 6366501
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of an angiotensin II antagonist on autoregulation in the isolated dog kidney.
    Kaloyanides GJ; DiBona GF
    Am J Physiol; 1976 Apr; 230(4):1078-83. PubMed ID: 1267003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugate effects of saralasin and indomethacin on kidney function in anesthetized dog.
    Tost H; Kövér G; Darvasi A
    Acta Physiol Hung; 1995; 83(1):63-77. PubMed ID: 7660839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
    Mimran A; Deschodt G; Barjon P; Mary H; Thevenet A
    Nouv Presse Med; 1978 Dec; 7(43):3889-93. PubMed ID: 733540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs.
    Arita M; Ueno Y; Suruda H; Mohara O; Nishio I; Masuyama Y
    Jpn Circ J; 1983 Mar; 47(3):336-41. PubMed ID: 6339771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.